Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb
Author:
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference40 articles.
1. TNF/TNFR family members in costimulation of T cell responses;Watts;Annu. Rev. Immunol.,2005
2. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses;Shuford;J. Exp. Med.,1997
3. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal;Takahashi;J. Immunol.,1999
4. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy;Cannons;J. Immunol.,2001
5. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors;Melero;Nat. Med.,1997
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. CD137+ T-Cells: Protagonists of the Immunotherapy Revolution;Cancers;2021-01-26
2. T-cell agonists in cancer immunotherapy;Journal for ImmunoTherapy of Cancer;2020-10
3. An Update on Anti-CD137 Antibodies in Immunotherapies for Cancer;International Journal of Molecular Sciences;2019-04-12
4. Optimized Gemcitabine Therapy in Combination with E7 Peptide Immunization Elicits Tumor Cure by Preventing Ag-Specific CTL Inhibition in Animals with Large Established Tumors;DNA and Cell Biology;2018-10
5. Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different;Trends in Immunology;2018-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3